| |
| |
|
| Insider
Information: |
Fust Matthew K |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
351,844 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,143,493 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
351,844 |
|
|
| Total
Value |
$8,143,493 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Jazz Pharmaceuticals Inc |
JAZZ |
EVP, Chief Financial O... |
2008-11-28 |
58,948 |
|
0 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Financial ... |
2013-10-01 |
0 |
2009-01-05 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-07 |
14,860 |
2014-01-30 |
0 |
Premium* |
|
|
Macrogenics Inc |
MGNX |
Director |
2019-02-06 |
500 |
|
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2024-03-31 |
259,000 |
2015-05-15 |
0 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
Director |
2024-03-20 |
18,536 |
2019-12-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
55,412 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-04-01 |
4 |
AS |
$86.13 |
$332,575 |
D/D |
(3,861) |
51,551 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-04-15 |
4 |
AS |
$95.15 |
$128,167 |
D/D |
(1,347) |
50,204 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-05-13 |
4 |
OE |
$34.48 |
$354,075 |
D/D |
10,269 |
60,473 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-05-13 |
4 |
AS |
$97.54 |
$1,008,598 |
D/D |
(10,269) |
50,204 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-07-02 |
4 |
AS |
$132.80 |
$205,973 |
D/D |
(1,551) |
48,838 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-07-26 |
4 |
AS |
$130.50 |
$788,612 |
D/D |
(6,043) |
42,795 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-08-08 |
4 |
AS |
$128.21 |
$319,499 |
D/D |
(2,492) |
40,303 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-10-01 |
4 |
D |
$125.00 |
$3,893,750 |
D/D |
(31,150) |
0 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Financial Officer |
• – – |
2013-10-01 |
4 |
D |
$125.00 |
$1,144,125 |
D/D |
(9,153) |
31,150 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2014-01-30 |
4 |
B |
$21.00 |
$105,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2014-03-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
500 |
|
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2015-03-19 |
4 |
OE |
$21.00 |
$132,699 |
D/D |
6,319 |
11,319 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,478 |
7,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,603 |
9,081 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2015-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,602 |
10,683 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,603 |
12,286 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2016-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,602 |
13,888 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
|
– • – |
2016-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
13,194 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2016-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,603 |
15,491 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2016-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,602 |
17,093 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
19,093 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,603 |
20,696 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,602 |
22,298 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Director |
– • – |
2017-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
27,298 |
0 |
- |
|
96 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
